• American Cancer Society updates colorectal cancer screening guideline to include new molecular tests

    The 2026 guideline update reaffirms screening starting at age 45 and adds newly FDA-approved molecular-based tests—a multitarget stool RNA test, a next-generation mt-sDNA test, and a blood-based cell-free DNA assay—to the list of screening options. (CA: A Cancer Journal for Clinicians)